Prosecution Insights
Last updated: October 27, 2026

Anna L Roberts, USPTO Patent Examiner

Listed by the USPTO as ROBERTS, ANNA L

Tech Center 3900 • Art Units: 1613 2872 3771 3783 3791 3792 3992

This examiner grants 56% of resolved cases

Analysis

ROBERTS, ANNA L is assigned to tech center 3900 and art unit 1613. The profile records 167 resolved cases and an allowance rate of 55.7%. Median time to allowance is 1287 days, making prosecution timing an important factor in client planning.

The interview lift is 39.8%, identifying interviews as a substantial feature of the recorded outcomes. The listed companies are Boston Scientific Corporation, Becton, Dickinson and Company, and Cardinal Health Inc. The listed firms are Knobbe, Martens, Olson & Bear, LLP, Maschoff Brennan (OC)(BD), and ARENTFOX SCHIFF LLP. Counsel may benefit from preparing a detailed interview strategy that links technical explanations and proposed amendments to the pending claims.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

55.7%
Allow Rate
-4.3% vs TC avg
236
Total Applications
+39.8%
Interview Lift
1287
Avg Prosecution Days
Based on 167 resolved cases, 2023–2026

Rejection Statute Breakdown

16.6%
§101 Eligibility
17.5%
§102 Novelty
39.1%
§103 Obviousness
22.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18900301 DETECTION OF GAIT ACTIVITY Non-Final OA Hoffmann-La Roche Inc.
18899966 Shape-Sensing Systems with Filters and Methods Thereof Final Rejection Bard Access Systems, Inc.
18755304 ACCURATE DETERMINATION OF RESPIRATORY RATES USING DEPTH-BASED CAMERA SYSTEM Final Rejection Covidien LP
18679019 BIOPSY FORCEPS WITH TISSUE PIERCING MEMBER Non-Final OA BOSTON SCIENTIFIC MEDICAL DEVICE LIMITED
18593198 Exchangeable Needle Safety Mechanism Final Rejection Boston Scientific Scimed Inc.
18356651 HEMOLYSIS-REDUCTION EXTENSION SET FOR DIRECT BLOOD DRAW Non-Final OA CAREFUSION 303, INC.
18315155 HEMOLYSIS-REDUCTION CONNECTOR FOR DIRECT BLOOD DRAW Non-Final OA CAREFUSION 303, INC.
18226550 SYSTEMS AND METHODS FOR DIABETES MANAGEMENT Final Rejection ABBOTT DIABETES CARE INC.
18889039 CARDIOVASCULAR HEALTH METRIC DETERMINATION FROM WEARABLE-BASED PHYSIOLOGICAL DATA Non-Final OA Oura Health Oy
18388711 RESUSCITATION AND VENTILATION ASYNCHRONY MONITOR Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
19082772 RING-SHAPED ELECTRONIC DEVICE COMPRISING OPTICAL COATING LAYER Non-Final OA RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY
18570581 USER ASSISTANCE SYSTEM, WEARABLE TERMINAL, AND USER ASSISTANCE METHOD Final Rejection MAXELL, LTD.
18994181 MINIATURE OPTICAL DEVICE FOR MONITORING LOCAL PULSE WAVE VELOCITY Non-Final OA Medtronic, Inc.
17623952 SLEEP-WAKEFULNESS DETERMINATION DEVICE AND PROGRAM Final Rejection THE UNIVERSITY OF TOKYO
19025501 CORE BODY TEMPERATURE MEASUREMENT Non-Final OA Masimo Corporation
18210093 ELONGATED MEDICAL DEVICE Non-Final OA Asahi Intecc Co., Ltd.
18634015 Vascular Probe Sensing System and Associated Delivery Device Non-Final OA Becton, Dickinson and Company
18574797 Sample Container for Capillary Blood Collection Final Rejection Becton, Dickinson and Company
18220503 Instrument Delivery System With Antimicrobial Features Non-Final OA Becton, Dickinson and Company
18656157 DISSECTING BETA WAVEFORMS USING CONVOLUTIONAL DICTIONARY LEARNING ACROSS SENSORY PERCEPTION, AGING, AND DISEASE Final Rejection Brown University
19049974 SYSTEM AND METHOD FOR LONGITUDINAL APNEA MONITORING USING SPO2 SIGNALS Non-Final OA UNIVERSITY OF SOUTH FLORIDA
18234761 PAIN THERAPY OPTIMIZATION USING A MOBILITY METRIC Non-Final OA Boston Scientific Neuromodulation Corporation
18032169 JOINT EVALUATION APPARATUS, METHOD, AND STORAGE MEDIUM Final Rejection OSAKA UNIVERSITY
18106050 URINE COLLECTION CUP Final Rejection FRIDABABY, LLC
18576753 Steerable instrument for endoscopic or invasive applications Final Rejection Fortimedix Assets II B.V.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Anna L Roberts's allowance rate?

55.7% of resolved applications examined by Anna L Roberts were allowed (167 resolved cases), compared with 34.0% across Art Unit 1613 over the last five years.

Does an interview help with examiner Anna L Roberts?

This examiner's interview lift is +39.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Anna L Roberts take to allow a patent?

Applications allowed by Anna L Roberts took 1,287 days on average from filing to allowance.

Which art unit does examiner Anna L Roberts work in?

Anna L Roberts examines applications in Art Unit 1613 in Tech Center 3900.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month